Ondine Biomedical Inc. (LON:OBI - Get Free Report) traded down 7.9% on Tuesday . The stock traded as low as C$12.00 and last traded at C$12.25. 53,936 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 429,282 shares. The stock had previously closed at C$13.30.
Ondine Biomedical Price Performance
The company has a quick ratio of 8.26, a current ratio of 1.36 and a debt-to-equity ratio of 25.95. The firm has a market capitalization of C$82.69 million, a price-to-earnings ratio of -3.47 and a beta of 0.10. The company's fifty day moving average is C$10.07 and its two-hundred day moving average is C$8.27.
Insider Buying and Selling at Ondine Biomedical
In related news, insider Carolyn Cross acquired 200,775 shares of the stock in a transaction dated Thursday, January 30th. The stock was bought at an average price of C$12.00 per share, with a total value of C$2,409,300.00. Insiders own 36.69% of the company's stock.
About Ondine Biomedical
(
Get Free Report)
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.
Featured Articles
Before you consider Ondine Biomedical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ondine Biomedical wasn't on the list.
While Ondine Biomedical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
